Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
astrazeneca
6
×
biotech
6
×
deals
6
×
life sciences
national blog main
san diego blog main
san diego top stories
texas blog main
boston blog main
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas top stories
wisconsin blog main
wisconsin top stories
boston top stories
cancer immunotherapy
europe blog main
europe top stories
fda
gilead sciences
merck
pfizer
abbvie
alzheimer's disease
amag pharmaceuticals
What
bio
roundup
acquisitions
amid
bombast
cancer
caught
ceo
coronavirus
daniel
debate
develop
discussion
drug
efforts
gilead
meso’s
miss
o’day
pandemic
pfizer’s
presidential
promise
response
sciences
tuesday’s
vaccine
viewers
additional
announced
approved
backing
based
biggest
build
buy
capital
cleveland
closes
collabs
Language
unset
Current search:
astrazeneca
×
biotech
×
deals
×
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: MESO’s Miss, Pfizer’s Cancer Bet, Vaccine Promise & More
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
RiverVest Venture Closes $184M Fund for Backing Healthcare Ventures
